nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP3A4—Fingolimod—multiple sclerosis	0.0961	0.196	CbGbCtD
Fenofibrate—CYP3A4—Methylprednisolone—multiple sclerosis	0.0619	0.127	CbGbCtD
Fenofibrate—CYP2C8—Dexamethasone—multiple sclerosis	0.0578	0.118	CbGbCtD
Fenofibrate—CYP3A4—Triamcinolone—multiple sclerosis	0.0469	0.096	CbGbCtD
Fenofibrate—CYP3A4—Mitoxantrone—multiple sclerosis	0.0452	0.0924	CbGbCtD
Fenofibrate—CYP2C9—Dexamethasone—multiple sclerosis	0.0403	0.0824	CbGbCtD
Fenofibrate—CYP3A4—Betamethasone—multiple sclerosis	0.0403	0.0823	CbGbCtD
Fenofibrate—CYP3A4—Prednisolone—multiple sclerosis	0.0397	0.0812	CbGbCtD
Fenofibrate—CYP3A4—Prednisone—multiple sclerosis	0.0375	0.0767	CbGbCtD
Fenofibrate—CYP3A4—Dexamethasone—multiple sclerosis	0.0234	0.0479	CbGbCtD
Fenofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00295	0.0772	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00295	0.0772	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors—PGR—multiple sclerosis	0.00126	0.0331	CbGpPWpGaD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.0012	0.0313	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000998	0.0261	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000965	0.0253	CbGpPWpGaD
Fenofibrate—PPARA—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.00089	0.0233	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptors—VDR—multiple sclerosis	0.000883	0.0231	CbGpPWpGaD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000778	0.0204	CbGpPWpGaD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000778	0.0204	CbGpPWpGaD
Fenofibrate—PPARA—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000697	0.0183	CbGpPWpGaD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000607	0.0159	CbGpPWpGaD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000607	0.0159	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—CD24—multiple sclerosis	0.000603	0.0158	CbGpPWpGaD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000599	0.0157	CbGpPWpGaD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000599	0.0157	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000571	0.015	CbGpPWpGaD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000513	0.0134	CbGpPWpGaD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000513	0.0134	CbGpPWpGaD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000494	0.0129	CbGpPWpGaD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000494	0.0129	CbGpPWpGaD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000492	0.0129	CbGpPWpGaD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000492	0.0129	CbGpPWpGaD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000488	0.0128	CbGpPWpGaD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000488	0.0128	CbGpPWpGaD
Fenofibrate—PPARA—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000475	0.0124	CbGpPWpGaD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.000474	0.0124	CbGpPWpGaD
Fenofibrate—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000454	0.0119	CbGpPWpGaD
Fenofibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.000443	0.0116	CbGpPWpGaD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000401	0.0105	CbGpPWpGaD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000401	0.0105	CbGpPWpGaD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000326	0.00853	CbGpPWpGaD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000326	0.00853	CbGpPWpGaD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000322	0.00842	CbGpPWpGaD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000322	0.00842	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000317	0.00829	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00031	0.00811	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00031	0.00811	CbGpPWpGaD
Fenofibrate—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000309	0.000655	CcSEcCtD
Fenofibrate—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000309	0.000655	CcSEcCtD
Fenofibrate—Discomfort—Triamcinolone—multiple sclerosis	0.000309	0.000654	CcSEcCtD
Fenofibrate—Discomfort—Methylprednisolone—multiple sclerosis	0.000308	0.000653	CcSEcCtD
Fenofibrate—Headache—Azathioprine—multiple sclerosis	0.000308	0.000652	CcSEcCtD
Fenofibrate—Dry mouth—Triamcinolone—multiple sclerosis	0.000306	0.000647	CcSEcCtD
Fenofibrate—Renal failure—Methotrexate—multiple sclerosis	0.000305	0.000646	CcSEcCtD
Fenofibrate—Angiopathy—Prednisone—multiple sclerosis	0.000303	0.00064	CcSEcCtD
Fenofibrate—Conjunctivitis—Methotrexate—multiple sclerosis	0.000302	0.000639	CcSEcCtD
Fenofibrate—Malaise—Dexamethasone—multiple sclerosis	0.000301	0.000636	CcSEcCtD
Fenofibrate—Malaise—Betamethasone—multiple sclerosis	0.000301	0.000636	CcSEcCtD
Fenofibrate—Oedema—Triamcinolone—multiple sclerosis	0.0003	0.000635	CcSEcCtD
Fenofibrate—Vertigo—Dexamethasone—multiple sclerosis	0.0003	0.000634	CcSEcCtD
Fenofibrate—Vertigo—Betamethasone—multiple sclerosis	0.0003	0.000634	CcSEcCtD
Fenofibrate—Arrhythmia—Prednisone—multiple sclerosis	0.000298	0.000631	CcSEcCtD
Fenofibrate—Infection—Triamcinolone—multiple sclerosis	0.000298	0.00063	CcSEcCtD
Fenofibrate—Sweating—Methotrexate—multiple sclerosis	0.000298	0.00063	CcSEcCtD
Fenofibrate—Infection—Methylprednisolone—multiple sclerosis	0.000297	0.000629	CcSEcCtD
Fenofibrate—Insomnia—Prednisolone—multiple sclerosis	0.000295	0.000624	CcSEcCtD
Fenofibrate—Alopecia—Prednisone—multiple sclerosis	0.000295	0.000624	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000294	0.000621	CcSEcCtD
Fenofibrate—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000293	0.000621	CcSEcCtD
Fenofibrate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000293	0.00062	CcSEcCtD
Fenofibrate—Paraesthesia—Prednisolone—multiple sclerosis	0.000293	0.00062	CcSEcCtD
Fenofibrate—Tachycardia—Triamcinolone—multiple sclerosis	0.000293	0.000619	CcSEcCtD
Fenofibrate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000292	0.00766	CbGpPWpGaD
Fenofibrate—Mental disorder—Prednisone—multiple sclerosis	0.000292	0.000618	CcSEcCtD
Fenofibrate—Nausea—Azathioprine—multiple sclerosis	0.000292	0.000618	CcSEcCtD
Fenofibrate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000292	0.000618	CcSEcCtD
Fenofibrate—Skin disorder—Methylprednisolone—multiple sclerosis	0.000291	0.000615	CcSEcCtD
Fenofibrate—Erythema—Prednisone—multiple sclerosis	0.00029	0.000614	CcSEcCtD
Fenofibrate—Malnutrition—Prednisone—multiple sclerosis	0.00029	0.000614	CcSEcCtD
Fenofibrate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00029	0.000613	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000289	0.000612	CcSEcCtD
Fenofibrate—Hypertension—Dexamethasone—multiple sclerosis	0.000288	0.000609	CcSEcCtD
Fenofibrate—Hypertension—Betamethasone—multiple sclerosis	0.000288	0.000609	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—FAS—multiple sclerosis	0.000288	0.00753	CbGpPWpGaD
Fenofibrate—Asthenia—Mitoxantrone—multiple sclerosis	0.000285	0.000603	CcSEcCtD
Fenofibrate—Myalgia—Dexamethasone—multiple sclerosis	0.000284	0.000601	CcSEcCtD
Fenofibrate—Myalgia—Betamethasone—multiple sclerosis	0.000284	0.000601	CcSEcCtD
Fenofibrate—Anxiety—Dexamethasone—multiple sclerosis	0.000283	0.000599	CcSEcCtD
Fenofibrate—Anxiety—Betamethasone—multiple sclerosis	0.000283	0.000599	CcSEcCtD
Fenofibrate—Discomfort—Betamethasone—multiple sclerosis	0.00028	0.000593	CcSEcCtD
Fenofibrate—Discomfort—Dexamethasone—multiple sclerosis	0.00028	0.000593	CcSEcCtD
Fenofibrate—Hypotension—Methylprednisolone—multiple sclerosis	0.00028	0.000592	CcSEcCtD
Fenofibrate—Pain—Prednisolone—multiple sclerosis	0.000279	0.00059	CcSEcCtD
Fenofibrate—Hepatitis—Methotrexate—multiple sclerosis	0.000279	0.00059	CcSEcCtD
Fenofibrate—Pharyngitis—Methotrexate—multiple sclerosis	0.000277	0.000585	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—ZNF746—multiple sclerosis	0.000275	0.0072	CbGpPWpGaD
Fenofibrate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000273	0.000578	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000273	0.000577	CcSEcCtD
Fenofibrate—Oedema—Dexamethasone—multiple sclerosis	0.000272	0.000576	CcSEcCtD
Fenofibrate—Oedema—Betamethasone—multiple sclerosis	0.000272	0.000576	CcSEcCtD
Fenofibrate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000272	0.000576	CcSEcCtD
Fenofibrate—Insomnia—Triamcinolone—multiple sclerosis	0.000271	0.000574	CcSEcCtD
Fenofibrate—Insomnia—Methylprednisolone—multiple sclerosis	0.000271	0.000573	CcSEcCtD
Fenofibrate—Infection—Betamethasone—multiple sclerosis	0.00027	0.000572	CcSEcCtD
Fenofibrate—Infection—Dexamethasone—multiple sclerosis	0.00027	0.000572	CcSEcCtD
Fenofibrate—Ill-defined disorder—Prednisone—multiple sclerosis	0.000269	0.00057	CcSEcCtD
Fenofibrate—Paraesthesia—Triamcinolone—multiple sclerosis	0.000269	0.00057	CcSEcCtD
Fenofibrate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000269	0.000569	CcSEcCtD
Fenofibrate—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000269	0.000569	CcSEcCtD
Fenofibrate—Visual impairment—Methotrexate—multiple sclerosis	0.000269	0.000568	CcSEcCtD
Fenofibrate—Anaemia—Prednisone—multiple sclerosis	0.000268	0.000568	CcSEcCtD
Fenofibrate—Dyspnoea—Triamcinolone—multiple sclerosis	0.000267	0.000566	CcSEcCtD
Fenofibrate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000267	0.000565	CcSEcCtD
Fenofibrate—Nervous system disorder—Betamethasone—multiple sclerosis	0.000267	0.000565	CcSEcCtD
Fenofibrate—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000266	0.000564	CcSEcCtD
Fenofibrate—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000266	0.000564	CcSEcCtD
Fenofibrate—Tachycardia—Dexamethasone—multiple sclerosis	0.000266	0.000562	CcSEcCtD
Fenofibrate—Tachycardia—Betamethasone—multiple sclerosis	0.000266	0.000562	CcSEcCtD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000264	0.00692	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000264	0.00692	CbGpPWpGaD
Fenofibrate—Dyspepsia—Triamcinolone—multiple sclerosis	0.000264	0.000559	CcSEcCtD
Fenofibrate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000263	0.000557	CcSEcCtD
Fenofibrate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000263	0.000557	CcSEcCtD
Fenofibrate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000263	0.000557	CcSEcCtD
Fenofibrate—Malaise—Prednisone—multiple sclerosis	0.000262	0.000554	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000261	0.00684	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000261	0.00684	CbGpPWpGaD
Fenofibrate—Vertigo—Prednisone—multiple sclerosis	0.000261	0.000552	CcSEcCtD
Fenofibrate—Eye disorder—Methotrexate—multiple sclerosis	0.000261	0.000551	CcSEcCtD
Fenofibrate—Anorexia—Betamethasone—multiple sclerosis	0.000259	0.000549	CcSEcCtD
Fenofibrate—Anorexia—Dexamethasone—multiple sclerosis	0.000259	0.000549	CcSEcCtD
Fenofibrate—Urticaria—Prednisolone—multiple sclerosis	0.000259	0.000548	CcSEcCtD
Fenofibrate—Cardiac disorder—Methotrexate—multiple sclerosis	0.000259	0.000547	CcSEcCtD
Fenofibrate—Fatigue—Triamcinolone—multiple sclerosis	0.000259	0.000547	CcSEcCtD
Fenofibrate—Fatigue—Methylprednisolone—multiple sclerosis	0.000258	0.000546	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000258	0.00675	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000258	0.00675	CbGpPWpGaD
Fenofibrate—Pain—Triamcinolone—multiple sclerosis	0.000256	0.000543	CcSEcCtD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000255	0.00667	CbGpPWpGaD
Fenofibrate—Hypotension—Dexamethasone—multiple sclerosis	0.000254	0.000538	CcSEcCtD
Fenofibrate—Hypotension—Betamethasone—multiple sclerosis	0.000254	0.000538	CcSEcCtD
Fenofibrate—Angiopathy—Methotrexate—multiple sclerosis	0.000253	0.000535	CcSEcCtD
Fenofibrate—Vomiting—Mitoxantrone—multiple sclerosis	0.000253	0.000535	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—PTBP1—multiple sclerosis	0.000252	0.00659	CbGpPWpGaD
Fenofibrate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000251	0.000532	CcSEcCtD
Fenofibrate—Hypertension—Prednisone—multiple sclerosis	0.000251	0.00053	CcSEcCtD
Fenofibrate—Rash—Mitoxantrone—multiple sclerosis	0.000251	0.00053	CcSEcCtD
Fenofibrate—Dermatitis—Mitoxantrone—multiple sclerosis	0.00025	0.00053	CcSEcCtD
Fenofibrate—Headache—Mitoxantrone—multiple sclerosis	0.000249	0.000527	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000248	0.000525	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000248	0.000525	CcSEcCtD
Fenofibrate—Arthralgia—Prednisone—multiple sclerosis	0.000247	0.000523	CcSEcCtD
Fenofibrate—Myalgia—Prednisone—multiple sclerosis	0.000247	0.000523	CcSEcCtD
Fenofibrate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000247	0.000523	CcSEcCtD
Fenofibrate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000247	0.000522	CcSEcCtD
Fenofibrate—Anxiety—Prednisone—multiple sclerosis	0.000246	0.000521	CcSEcCtD
Fenofibrate—Alopecia—Methotrexate—multiple sclerosis	0.000246	0.000521	CcSEcCtD
Fenofibrate—Insomnia—Betamethasone—multiple sclerosis	0.000246	0.000521	CcSEcCtD
Fenofibrate—Insomnia—Dexamethasone—multiple sclerosis	0.000246	0.000521	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000245	0.000519	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000245	0.000518	CcSEcCtD
Fenofibrate—Paraesthesia—Betamethasone—multiple sclerosis	0.000244	0.000517	CcSEcCtD
Fenofibrate—Paraesthesia—Dexamethasone—multiple sclerosis	0.000244	0.000517	CcSEcCtD
Fenofibrate—Discomfort—Prednisone—multiple sclerosis	0.000244	0.000517	CcSEcCtD
Fenofibrate—Mental disorder—Methotrexate—multiple sclerosis	0.000244	0.000517	CcSEcCtD
Fenofibrate—Malnutrition—Methotrexate—multiple sclerosis	0.000243	0.000513	CcSEcCtD
Fenofibrate—Erythema—Methotrexate—multiple sclerosis	0.000243	0.000513	CcSEcCtD
Fenofibrate—Hypersensitivity—Prednisolone—multiple sclerosis	0.00024	0.000508	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00024	0.00628	CbGpPWpGaD
Fenofibrate—Dyspepsia—Dexamethasone—multiple sclerosis	0.00024	0.000507	CcSEcCtD
Fenofibrate—Dyspepsia—Betamethasone—multiple sclerosis	0.00024	0.000507	CcSEcCtD
Fenofibrate—Urticaria—Triamcinolone—multiple sclerosis	0.000238	0.000504	CcSEcCtD
Fenofibrate—Urticaria—Methylprednisolone—multiple sclerosis	0.000238	0.000503	CcSEcCtD
Fenofibrate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000237	0.000502	CcSEcCtD
Fenofibrate—Oedema—Prednisone—multiple sclerosis	0.000237	0.000501	CcSEcCtD
Fenofibrate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000237	0.000501	CcSEcCtD
Fenofibrate—Decreased appetite—Betamethasone—multiple sclerosis	0.000237	0.000501	CcSEcCtD
Fenofibrate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000237	0.000501	CcSEcCtD
Fenofibrate—Nausea—Mitoxantrone—multiple sclerosis	0.000236	0.0005	CcSEcCtD
Fenofibrate—Infection—Prednisone—multiple sclerosis	0.000235	0.000498	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000235	0.000497	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000235	0.000497	CcSEcCtD
Fenofibrate—Back pain—Methotrexate—multiple sclerosis	0.000235	0.000497	CcSEcCtD
Fenofibrate—Fatigue—Dexamethasone—multiple sclerosis	0.000235	0.000496	CcSEcCtD
Fenofibrate—Fatigue—Betamethasone—multiple sclerosis	0.000235	0.000496	CcSEcCtD
Fenofibrate—Pain—Betamethasone—multiple sclerosis	0.000233	0.000492	CcSEcCtD
Fenofibrate—Pain—Dexamethasone—multiple sclerosis	0.000233	0.000492	CcSEcCtD
Fenofibrate—Nervous system disorder—Prednisone—multiple sclerosis	0.000232	0.000492	CcSEcCtD
Fenofibrate—Tachycardia—Prednisone—multiple sclerosis	0.000231	0.000489	CcSEcCtD
Fenofibrate—Skin disorder—Prednisone—multiple sclerosis	0.00023	0.000487	CcSEcCtD
Fenofibrate—Hyperhidrosis—Prednisone—multiple sclerosis	0.000229	0.000485	CcSEcCtD
Fenofibrate—Anorexia—Prednisone—multiple sclerosis	0.000226	0.000478	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000225	0.000476	CcSEcCtD
Fenofibrate—Anaemia—Methotrexate—multiple sclerosis	0.000224	0.000475	CcSEcCtD
Fenofibrate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000224	0.000475	CcSEcCtD
Fenofibrate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000224	0.000475	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000223	0.000471	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000223	0.000471	CcSEcCtD
Fenofibrate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000221	0.000468	CcSEcCtD
Fenofibrate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00022	0.000467	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—multiple sclerosis	0.000219	0.000463	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—multiple sclerosis	0.000218	0.000461	CcSEcCtD
Fenofibrate—Leukopenia—Methotrexate—multiple sclerosis	0.000217	0.00046	CcSEcCtD
Fenofibrate—Urticaria—Dexamethasone—multiple sclerosis	0.000216	0.000457	CcSEcCtD
Fenofibrate—Urticaria—Betamethasone—multiple sclerosis	0.000216	0.000457	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000216	0.000457	CcSEcCtD
Fenofibrate—Dizziness—Prednisolone—multiple sclerosis	0.000216	0.000456	CcSEcCtD
Fenofibrate—Asthenia—Triamcinolone—multiple sclerosis	0.000215	0.000455	CcSEcCtD
Fenofibrate—Body temperature increased—Betamethasone—multiple sclerosis	0.000215	0.000455	CcSEcCtD
Fenofibrate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000215	0.000455	CcSEcCtD
Fenofibrate—Abdominal pain—Betamethasone—multiple sclerosis	0.000215	0.000455	CcSEcCtD
Fenofibrate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000215	0.000455	CcSEcCtD
Fenofibrate—Asthenia—Methylprednisolone—multiple sclerosis	0.000215	0.000454	CcSEcCtD
Fenofibrate—Insomnia—Prednisone—multiple sclerosis	0.000214	0.000454	CcSEcCtD
Fenofibrate—Paraesthesia—Prednisone—multiple sclerosis	0.000213	0.00045	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000213	0.00557	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000213	0.00557	CbGpPWpGaD
Fenofibrate—Pruritus—Triamcinolone—multiple sclerosis	0.000212	0.000449	CcSEcCtD
Fenofibrate—Cough—Methotrexate—multiple sclerosis	0.000212	0.000448	CcSEcCtD
Fenofibrate—Pruritus—Methylprednisolone—multiple sclerosis	0.000212	0.000448	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00021	0.00549	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00021	0.00549	CbGpPWpGaD
Fenofibrate—Dyspepsia—Prednisone—multiple sclerosis	0.000209	0.000441	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—multiple sclerosis	0.000207	0.000437	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—multiple sclerosis	0.000207	0.000437	CcSEcCtD
Fenofibrate—Myalgia—Methotrexate—multiple sclerosis	0.000207	0.000437	CcSEcCtD
Fenofibrate—Decreased appetite—Prednisone—multiple sclerosis	0.000206	0.000436	CcSEcCtD
Fenofibrate—Rash—Prednisolone—multiple sclerosis	0.000206	0.000435	CcSEcCtD
Fenofibrate—Dermatitis—Prednisolone—multiple sclerosis	0.000205	0.000435	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000205	0.000434	CcSEcCtD
Fenofibrate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000205	0.000433	CcSEcCtD
Fenofibrate—Fatigue—Prednisone—multiple sclerosis	0.000204	0.000432	CcSEcCtD
Fenofibrate—Headache—Prednisolone—multiple sclerosis	0.000204	0.000432	CcSEcCtD
Fenofibrate—Discomfort—Methotrexate—multiple sclerosis	0.000204	0.000432	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—FAS—multiple sclerosis	0.000203	0.00532	CbGpPWpGaD
Fenofibrate—Constipation—Prednisone—multiple sclerosis	0.000203	0.000429	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—PRNP—multiple sclerosis	0.000199	0.00521	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000199	0.00521	CbGpPWpGaD
Fenofibrate—Dizziness—Triamcinolone—multiple sclerosis	0.000198	0.00042	CcSEcCtD
Fenofibrate—Dizziness—Methylprednisolone—multiple sclerosis	0.000198	0.000419	CcSEcCtD
Fenofibrate—Infection—Methotrexate—multiple sclerosis	0.000197	0.000416	CcSEcCtD
Fenofibrate—PPARA—Metabolism—SRM—multiple sclerosis	0.000196	0.00512	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Prednisone—multiple sclerosis	0.000195	0.000413	CcSEcCtD
Fenofibrate—Asthenia—Betamethasone—multiple sclerosis	0.000195	0.000413	CcSEcCtD
Fenofibrate—Asthenia—Dexamethasone—multiple sclerosis	0.000195	0.000413	CcSEcCtD
Fenofibrate—Nervous system disorder—Methotrexate—multiple sclerosis	0.000194	0.000411	CcSEcCtD
Fenofibrate—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000194	0.00041	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000194	0.00041	CcSEcCtD
Fenofibrate—Nausea—Prednisolone—multiple sclerosis	0.000194	0.00041	CcSEcCtD
Fenofibrate—Pruritus—Dexamethasone—multiple sclerosis	0.000193	0.000407	CcSEcCtD
Fenofibrate—Pruritus—Betamethasone—multiple sclerosis	0.000193	0.000407	CcSEcCtD
Fenofibrate—Skin disorder—Methotrexate—multiple sclerosis	0.000192	0.000407	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000191	0.000405	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—HNRNPA1—multiple sclerosis	0.000191	0.00499	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—U2AF2—multiple sclerosis	0.000191	0.00499	CbGpPWpGaD
Fenofibrate—Vomiting—Triamcinolone—multiple sclerosis	0.000191	0.000403	CcSEcCtD
Fenofibrate—Vomiting—Methylprednisolone—multiple sclerosis	0.00019	0.000403	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00019	0.00497	CbGpPWpGaD
Fenofibrate—Rash—Triamcinolone—multiple sclerosis	0.000189	0.0004	CcSEcCtD
Fenofibrate—Dermatitis—Triamcinolone—multiple sclerosis	0.000189	0.0004	CcSEcCtD
Fenofibrate—Anorexia—Methotrexate—multiple sclerosis	0.000189	0.000399	CcSEcCtD
Fenofibrate—Rash—Methylprednisolone—multiple sclerosis	0.000189	0.000399	CcSEcCtD
Fenofibrate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000188	0.000399	CcSEcCtD
Fenofibrate—Urticaria—Prednisone—multiple sclerosis	0.000188	0.000398	CcSEcCtD
Fenofibrate—Headache—Triamcinolone—multiple sclerosis	0.000188	0.000398	CcSEcCtD
Fenofibrate—Headache—Methylprednisolone—multiple sclerosis	0.000187	0.000397	CcSEcCtD
Fenofibrate—Abdominal pain—Prednisone—multiple sclerosis	0.000187	0.000396	CcSEcCtD
Fenofibrate—Body temperature increased—Prednisone—multiple sclerosis	0.000187	0.000396	CcSEcCtD
Fenofibrate—Diarrhoea—Betamethasone—multiple sclerosis	0.000186	0.000394	CcSEcCtD
Fenofibrate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000186	0.000394	CcSEcCtD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000186	0.00486	CbGpPWpGaD
Fenofibrate—Hypotension—Methotrexate—multiple sclerosis	0.000185	0.000392	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00018	0.000382	CcSEcCtD
Fenofibrate—Dizziness—Betamethasone—multiple sclerosis	0.00018	0.000381	CcSEcCtD
Fenofibrate—Dizziness—Dexamethasone—multiple sclerosis	0.00018	0.000381	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—multiple sclerosis	0.000179	0.000379	CcSEcCtD
Fenofibrate—Nausea—Triamcinolone—multiple sclerosis	0.000178	0.000377	CcSEcCtD
Fenofibrate—Paraesthesia—Methotrexate—multiple sclerosis	0.000178	0.000376	CcSEcCtD
Fenofibrate—Nausea—Methylprednisolone—multiple sclerosis	0.000178	0.000376	CcSEcCtD
Fenofibrate—Dyspnoea—Methotrexate—multiple sclerosis	0.000177	0.000374	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—multiple sclerosis	0.000176	0.000373	CcSEcCtD
Fenofibrate—Hypersensitivity—Prednisone—multiple sclerosis	0.000175	0.000369	CcSEcCtD
Fenofibrate—Dyspepsia—Methotrexate—multiple sclerosis	0.000174	0.000369	CcSEcCtD
Fenofibrate—Vomiting—Betamethasone—multiple sclerosis	0.000173	0.000366	CcSEcCtD
Fenofibrate—Vomiting—Dexamethasone—multiple sclerosis	0.000173	0.000366	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—PGR—multiple sclerosis	0.000172	0.00451	CbGpPWpGaD
Fenofibrate—Decreased appetite—Methotrexate—multiple sclerosis	0.000172	0.000364	CcSEcCtD
Fenofibrate—Rash—Dexamethasone—multiple sclerosis	0.000172	0.000363	CcSEcCtD
Fenofibrate—Rash—Betamethasone—multiple sclerosis	0.000172	0.000363	CcSEcCtD
Fenofibrate—Dermatitis—Betamethasone—multiple sclerosis	0.000171	0.000363	CcSEcCtD
Fenofibrate—Dermatitis—Dexamethasone—multiple sclerosis	0.000171	0.000363	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000171	0.000362	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—multiple sclerosis	0.000171	0.000361	CcSEcCtD
Fenofibrate—Headache—Betamethasone—multiple sclerosis	0.00017	0.000361	CcSEcCtD
Fenofibrate—Headache—Dexamethasone—multiple sclerosis	0.00017	0.000361	CcSEcCtD
Fenofibrate—Asthenia—Prednisone—multiple sclerosis	0.00017	0.00036	CcSEcCtD
Fenofibrate—Pain—Methotrexate—multiple sclerosis	0.000169	0.000358	CcSEcCtD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000168	0.0044	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000168	0.00439	CbGpPWpGaD
Fenofibrate—Pruritus—Prednisone—multiple sclerosis	0.000168	0.000355	CcSEcCtD
Fenofibrate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000163	0.000345	CcSEcCtD
Fenofibrate—Diarrhoea—Prednisone—multiple sclerosis	0.000162	0.000343	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000162	0.000343	CcSEcCtD
Fenofibrate—Nausea—Dexamethasone—multiple sclerosis	0.000162	0.000342	CcSEcCtD
Fenofibrate—Nausea—Betamethasone—multiple sclerosis	0.000162	0.000342	CcSEcCtD
Fenofibrate—Urticaria—Methotrexate—multiple sclerosis	0.000157	0.000333	CcSEcCtD
Fenofibrate—Dizziness—Prednisone—multiple sclerosis	0.000157	0.000332	CcSEcCtD
Fenofibrate—Abdominal pain—Methotrexate—multiple sclerosis	0.000157	0.000331	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—multiple sclerosis	0.000157	0.000331	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—PTPRC—multiple sclerosis	0.000155	0.00405	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—ZFP36L1—multiple sclerosis	0.000151	0.00395	CbGpPWpGaD
Fenofibrate—Vomiting—Prednisone—multiple sclerosis	0.000151	0.000319	CcSEcCtD
Fenofibrate—Rash—Prednisone—multiple sclerosis	0.000149	0.000316	CcSEcCtD
Fenofibrate—Dermatitis—Prednisone—multiple sclerosis	0.000149	0.000316	CcSEcCtD
Fenofibrate—Headache—Prednisone—multiple sclerosis	0.000148	0.000314	CcSEcCtD
Fenofibrate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000146	0.000309	CcSEcCtD
Fenofibrate—Asthenia—Methotrexate—multiple sclerosis	0.000142	0.000301	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—STAT3—multiple sclerosis	0.000141	0.0037	CbGpPWpGaD
Fenofibrate—Nausea—Prednisone—multiple sclerosis	0.000141	0.000298	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.00014	0.00367	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.00014	0.00367	CbGpPWpGaD
Fenofibrate—Pruritus—Methotrexate—multiple sclerosis	0.00014	0.000296	CcSEcCtD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000138	0.00362	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000138	0.00362	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP24A1—multiple sclerosis	0.000138	0.00361	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP27B1—multiple sclerosis	0.000138	0.00361	CbGpPWpGaD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000137	0.00358	CbGpPWpGaD
Fenofibrate—Diarrhoea—Methotrexate—multiple sclerosis	0.000136	0.000287	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000135	0.00353	CbGpPWpGaD
Fenofibrate—Dizziness—Methotrexate—multiple sclerosis	0.000131	0.000277	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—TGFB1—multiple sclerosis	0.000131	0.00343	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GPC5—multiple sclerosis	0.000126	0.0033	CbGpPWpGaD
Fenofibrate—Vomiting—Methotrexate—multiple sclerosis	0.000126	0.000266	CcSEcCtD
Fenofibrate—Rash—Methotrexate—multiple sclerosis	0.000125	0.000264	CcSEcCtD
Fenofibrate—Dermatitis—Methotrexate—multiple sclerosis	0.000125	0.000264	CcSEcCtD
Fenofibrate—Headache—Methotrexate—multiple sclerosis	0.000124	0.000263	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—TNF—multiple sclerosis	0.000122	0.0032	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—VDR—multiple sclerosis	0.00012	0.00315	CbGpPWpGaD
Fenofibrate—Nausea—Methotrexate—multiple sclerosis	0.000118	0.000249	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—PABPC1—multiple sclerosis	0.000117	0.00306	CbGpPWpGaD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000111	0.00291	CbGpPWpGaD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000111	0.0029	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—RPL5—multiple sclerosis	0.000105	0.00276	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—RRM1—multiple sclerosis	0.000104	0.00274	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.0001	0.00263	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.0001	0.00263	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—IL6—multiple sclerosis	9.86e-05	0.00258	CbGpPWpGaD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.01e-05	0.00236	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—PGR—multiple sclerosis	8.3e-05	0.00217	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.17e-05	0.00214	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.17e-05	0.00214	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.11e-05	0.00212	CbGpPWpGaD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.33e-05	0.00192	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.96e-05	0.00182	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—IL6—multiple sclerosis	6.96e-05	0.00182	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—TYK2—multiple sclerosis	6.93e-05	0.00181	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.35e-05	0.00166	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SRM—multiple sclerosis	6.34e-05	0.00166	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.04e-05	0.00158	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—BCHE—multiple sclerosis	6e-05	0.00157	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.94e-05	0.00156	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.88e-05	0.00154	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—VDR—multiple sclerosis	5.8e-05	0.00152	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—MMP9—multiple sclerosis	5.46e-05	0.00143	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SRM—multiple sclerosis	5.16e-05	0.00135	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—STAT3—multiple sclerosis	4.85e-05	0.00127	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—MYC—multiple sclerosis	4.79e-05	0.00125	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.79e-05	0.00125	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—TGFB1—multiple sclerosis	4.5e-05	0.00118	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.47e-05	0.00117	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.47e-05	0.00117	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—MAPK1—multiple sclerosis	4.41e-05	0.00115	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.37e-05	0.00114	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—TNF—multiple sclerosis	4.2e-05	0.0011	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GPC5—multiple sclerosis	4.09e-05	0.00107	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.64e-05	0.000953	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.64e-05	0.000953	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—APOE—multiple sclerosis	3.61e-05	0.000945	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.56e-05	0.000931	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SRM—multiple sclerosis	3.41e-05	0.000892	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—IL6—multiple sclerosis	3.39e-05	0.000887	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.39e-05	0.000887	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.33e-05	0.000871	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.16e-05	0.000826	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—POMC—multiple sclerosis	3.1e-05	0.000812	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ALB—multiple sclerosis	2.83e-05	0.00074	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.76e-05	0.000722	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.63e-05	0.000688	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.4e-05	0.000628	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.4e-05	0.000628	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MYC—multiple sclerosis	2.31e-05	0.000604	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.26e-05	0.000591	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.19e-05	0.000575	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.14e-05	0.00056	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.06e-05	0.000539	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.95e-05	0.000509	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.84e-05	0.000481	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.82e-05	0.000476	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.68e-05	0.000439	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.58e-05	0.000415	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—APOE—multiple sclerosis	1.17e-05	0.000307	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.04e-05	0.000273	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—POMC—multiple sclerosis	1.01e-05	0.000263	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—APOE—multiple sclerosis	9.53e-06	0.000249	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALB—multiple sclerosis	9.17e-06	0.00024	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—POMC—multiple sclerosis	8.18e-06	0.000214	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALB—multiple sclerosis	7.46e-06	0.000195	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—APOE—multiple sclerosis	6.28e-06	0.000165	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—POMC—multiple sclerosis	5.4e-06	0.000141	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALB—multiple sclerosis	4.92e-06	0.000129	CbGpPWpGaD
